课题基金 / 基金详情

A Robust and Low-cost Technology for Risk Mitigation of Pathogenic Infection in HVAC Systems

A Robust and Low-cost Technology for Risk Mitigation of Pathogenic Infection in HVAC Systems
用于降低 HVAC 系统病原体感染风险的稳健且低成本的技术
批准号:
567653-2021
负责人:
Nouri, AlirezaA
金额:
$6.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project develops an innovative technology to entrap and destroy pathogens suspended in the air in ventilated buildings. Several infectious germs, such as coronavirus and influenza, may travel in the Heating, Ventilation, and Air Conditioning (HVAC) system while encapsulated in minute droplets. The HVAC ducts can serve as conduits for the circulation and spread of infectious diseases in the building. Further, all HVAC filters entrap and accumulate microbes to the extent that depends on the filter specification and filter replacement frequency. Accumulation of microbes in the filter can turn the filter into a breeding ground for fungi and bacteria, making the filter a biologically hazardous object. Hence, the filter disposal may become hazardous unless a safe disposal protocol is followed to minimize the risks. Also, any change or disturbance in the airflow may release some of the microbes into the environment. In the past, Ultraviolet (UV) light has been employed to reduce biological contaminants in the air. However, the installation of existing technology in the HVAC system is not easily possible and is limited by the HVAC system's design. For more conventional HVAC systems such as duct-based systems, installing such units is often costly and labour-intensive. Hence, such units are seldom used in HVAC systems outside the healthcare buildings. This project develops a compact and economical device that works based on entrapping microbes by the HVAC filters and inactivating them by heating. The aim is to conduct proof of concept tests, build the prototype, develop efficient, optimal and cost-effective units, and advance guidelines for the geometries/configurations, materials, operations, and specifications. All ventilated buildings such as hospitals/clinics, high-rises, and care facilities can benefit from this technology. The technology can eliminate the microbes effectively and can easily be installed in existing and new HVAC systems. Calculations indicate more efficient microbial inactivation than existing UV technologies at a fraction of the cost. The technology is expected to be commercialized by the industrial partner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    耿林玉
  • 依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
  • 批准号:
    82271095
  • 项目类别:
    面上项目
  • 资助金额:
    56万元
  • 批准年份:
    2022
  • 负责人:
    柳夏林
  • 依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
  • 批准号:
    82270883
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    毕艳
  • 依托单位: